These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 989600)

  • 1. Incidence of hypothyroidism following small doses of 131I in the treatment of Graves' disease.
    McCullagh EP; Jelden GL; Rodriguez-Antunez A
    Ohio State Med J; 1976 Sep; 72(9):538-40. PubMed ID: 989600
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term results following 131I treatment for Graves' disease in Hong Kong Chinese--discriminant factors predicting hypothyroidism.
    Kung AW; Pun KK; Lam KS; Choi P; Wang C; Yeung RT
    Q J Med; 1990 Sep; 76(281):961-7. PubMed ID: 2236479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease.
    Sridama V; McCormick M; Kaplan EL; Fauchet R; DeGroot LJ
    N Engl J Med; 1984 Aug; 311(7):426-32. PubMed ID: 6205272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal iodine-131 dose in Graves' disease.
    Schober B; Cohen P; Lentle B
    J Nucl Med; 1991 Dec; 32(12):2359-60. PubMed ID: 1801809
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of treatment of Graves-Basedow disease with 131I at low calculated doses].
    Gómez Arnaiz N; Gómez Saez JM; Orti Llavería A; Gavaldá Mestre L; Mairal Pairó L; Soler Ramón J
    Rev Clin Esp; 1998 Feb; 198(2):57-60. PubMed ID: 9558917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simplified method for treating Graves' disease with radioactive 131I.
    Masri MT; Menne M; Rooney BL; Caplan RH
    Wis Med J; 1995 Jan; 94(1):21-5. PubMed ID: 7871797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal hypothyroidism following treatment of Graves' disease: a preventable complication.
    Winternitz SR; Winternitz WW
    J Ky Med Assoc; 1976 Sep; 74(9):459-60. PubMed ID: 989494
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of influential factors correlating with early and late hypothyroidism after (131)I therapy for Graves' disease.
    Wang RF; Tan J; Zhang GZ; Meng ZW; Zheng W
    Chin Med J (Engl); 2010 Jun; 123(12):1528-32. PubMed ID: 20819506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early results of 125I therapy of thyrotoxic Graves' disease.
    Siemsen JK; Wallack MS; Martin RB; Nicoloff JT
    J Nucl Med; 1974 Apr; 15(4):257-60. PubMed ID: 4406129
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence of hypothyroidism after radioiodine treatment for Graves disease.
    Rosado M; Borrego LC; Paniagua ME
    Bol Asoc Med P R; 1983 Apr; 75(4):167-9. PubMed ID: 6575789
    [No Abstract]   [Full Text] [Related]  

  • 11. Transient hypothyroidism after iodine-131 treatment of Graves' disease.
    Gómez JM; Virgili N; Soler J; Fernández M; Montaña E
    Thyroidology; 1989 Dec; 1(3):149-52. PubMed ID: 2484879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Graves-Basedow's disease with 131I. Assessment of a "modulated fixed activity" protocol].
    Abós D; Ruiz P; Prats E; Razola P; García F; Tardín L; Banzo J
    Rev Esp Med Nucl; 2007; 26(1):3-10. PubMed ID: 17286943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radiotherapy with 131J and 125J of Basedow's disease. Indications and results relative to the incidence of post-actinic hypothyroidism].
    Dradi C; Riceputi G; Biagioli R; Riva P
    Minerva Med; 1979 Jan; 70(2):135-41. PubMed ID: 581903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of nuclear medicine in the management of Graves' disease.
    Freitas JE
    Q J Nucl Med; 1999 Dec; 43(4):297-306. PubMed ID: 10731780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
    Hegele RA; Volpé R
    J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine-induced hypothyroidism in Graves' disease: factors associated.
    Cunnien AJ; Hay ID; Gorman CA; Offord KP; Scanlon PW
    J Nucl Med; 1982 Nov; 23(11):978-83. PubMed ID: 6897075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypothyroidism caused by radioiodine therapy].
    Miclulţia M; Derevenco V; Holan T
    Stud Cercet Endocrinol; 1972; 23(4):263-9. PubMed ID: 4681800
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves' disease.
    Nygaard B; Hegedüs L; Gervil M; Hjalgrim H; Hansen BM; Søe-Jensen P; Hansen JM
    J Intern Med; 1995 Dec; 238(6):491-7. PubMed ID: 9422034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Short-term course of Graves-Basedow disease treated with I131. Prevalence of transient hypothyroidism].
    Virgili N; Gómez JM; Montaña E; Soler J; Castells M; Roca M
    Rev Clin Esp; 1988 Oct; 183(6):300-3. PubMed ID: 3217548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.